Allurion Technologies, Inc. (ALUR): EBITDA
-$29.17M
Year ended 2025-12-31
-$25.66M
Trailing 12 months to 2026-03-31
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$29.17M | n/m | 2026-03-30, From 2025-01-01 |
| 2024-12-31 | -$49.20M | n/m | 2026-03-30, From 2024-01-01 |
| 2023-12-31 | -$78.33M | n/m | 2025-08-28, From 2023-01-01 |
| 2022-12-31 | -$31.11M | n/a | 2025-08-28, From 2022-01-01 |
EBITDA at similar companies
| Company | Year ended | EBITDA | Change YoY |
|---|---|---|---|
| Allurion Technologies, Inc. (ALUR) | 2025-12-31 | -$29.17M | n/m |
| Vivos Therapeutics, Inc. (VVOS) | 2025-12-31 | -$18.59M | n/m |
| Nephros Inc (NEPH) | 2025-12-31 | $1.29M | +812.1% |
| Sonoma Pharmaceuticals, Inc. (SNOA) | 2026-03-31 | -$2.32M | n/m |
| Nexgel, Inc. (NXGL) | 2025-12-31 | -$2.90M | n/m |
| Baird Medical Investment Holdings Ltd (BDMD) | 2025-12-31 | -$24.53M | n/m |
| Medinotec Inc. (MDNC) | 2026-02-28 | $1.18M | -64.0% |
| Neuroone Medical Technologies Corp (NMTC) | 2025-09-30 | -$3.96M | n/m |
| InspireMD, Inc. (NSPR) | 2025-12-31 | $426.39M | +73.0% |
Compare ALUR, VVOS, NEPH, SNOA side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗